Free provider profile
HORACIO CAPOTE, M.D.
NPI 1053475939
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2017-02-09.
3980 SHERIDAN DR STE 500 DENT NEUROLOGIC GROUP, LLP, AMHERST, NY, 14226
716-250-2000
Single practice location
Enumerated 2006-12-21
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 5 payer identifiers on file — enrolled with payers.
- — Record last updated 9 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
2,242
Medicare patients
397
Part D drug cost
$1,133,174
Brand-name share
17.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Caplyta (Lumateperone Tosylate) | 72 | $120,371 |
| Invega Sustenna (Paliperidone Palmitate) | 30 | $102,648 |
| Nuplazid (Pimavanserin Tartrate) | 18 | $90,775 |
| Rexulti (Brexpiprazole) | 48 | $68,546 |
| Vraylar (Cariprazine Hcl) | 37 | $65,314 |
| Abilify Maintena (Aripiprazole) | 21 | $58,285 |
| Nuedexta (Dextromethorphan Hbr/Quinidine) | 30 | $56,352 |
| Trintellix (Vortioxetine Hydrobromide) | 62 | $48,861 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024347 sessions · 17 patients · $313,612
2023203 sessions · 13 patients · $180,269
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.